Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
10 p, 917.8 KB Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins / Díez, José María (Grifols. Bioscience Research & Development) ; Romero, Carolina (Grifols. Bioscience Research & Development) ; Vergara-Alert, Júlia (Institut de Recerca i Tecnologia Agroalimentàries. Centre de Recerca en Sanitat Animal) ; Belló-Perez, Melissa (Laboratorio Coronavirus. Departamento de Biología Molecular y Celular) ; Rodon, Jordi (Institut de Recerca i Tecnologia Agroalimentàries. Centre de Recerca en Sanitat Animal) ; Honrubia, José Manuel (Laboratorio Coronavirus. Departamento de Biología Molecular y Celular) ; Segalés Coma, Joaquim (Universitat Autònoma de Barcelona. Departament de Sanitat i d'Anatomia Animals) ; Sola, Isabel (Laboratorio Coronavirus. Departamento de Biología Molecular y Celular) ; Enjuanes, Luis (Laboratorio Coronavirus. Departamento de Biología Molecular y Celular) ; Gajardo, Rodrigo (Grifols. Bioscience Research & Development)
Background: Cross-reactivity against human coronaviruses with Flebogamma ® DIF and Gamunex ® -C, two available intravenous immunoglobulins (IVIG), has been reported. In this study, these IVIG were tested for neutralization activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), SARS-CoV and Middle East respiratory syndrome CoV (MERS-CoV). [...]
2020 - 10.2217/imt-2020-0220
Immunotherapy, september 2020  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.